Higher dose of mesalamine can decrease risk of relapse for patients with quiescent ulcerative colitis

Increasing dosages of mesalamine by 2.4 g/d for patients with quiescent ulcerative colitis can dramatically reduce concentrations of fecal calprotectin and ultimately decrease the likelihood of...